MaxCyte Board Member Richard Douglas, PhD, Appointed

GAITHERSBURG, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT, MXCN) is a leading commercial cell-engineering company...

Related Keywords

United Kingdom ,Michigan ,United States ,David Deuchler ,Doug Doerfler ,Richard Douglas ,Laura Morgan ,Chris Welsh ,Mary Jane Elliott ,Panmure Gordon ,Emma Earl Freddy Crossley ,Rupert Dearden ,Maxcyte Inc ,Sam Brown Healthcare Communications ,Nasdaq ,University Of Michigan ,Corporate Development ,Gilmartin Group ,National Advisory Board Of Innovation Partnerships ,Consilium Strategic Communications ,Genzyme Corporation ,Novavax Inc ,Board Member ,Board Chair ,Redsky Partners ,Aldeyra Therapeutics ,National Advisory Board ,Innovation Partnerships ,Senior Vice President ,Corporate Officer ,Chief Executive Officer ,Flow Electroporation ,Cyte Contacts ,Joint Corporate ,Nasdaq Mxct ,Maxcyte ,Nc ,